Using a single medication alone can lead to drug resistance. Most DAAs are only available as part of a combination pill. The first-generation hepatitis C protease inhibitors, boceprevir (Victrelis) ...

Early prescription data show doctors' preference for Vertex's Hep C drug Incivek over a rival drug from Merck launched at the same time. in May just 10 days apart, which means Vertex and Merck ...

In May 2011, Roche and MSD (known as Merck in the US) struck a deal to co-promote Victrelis, Merck’s new treatment for chronic hepatitis C. More unusually, the two companies also agreed to pool ...

George Njoroge -- a renowned Kenyan researcher who in 2011 discovered Victrelis, the first oral protease inhibitor that cured Hepatitis C -- is behind the plan. Under the plan, a team of experts ...